CBT Relative Valuation
CBT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CBT is overvalued; if below, it's undervalued.
Historical Valuation
Cabot Corp (CBT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.70 is considered Undervalued compared with the five-year average of 11.42. The fair price of Cabot Corp (CBT) is between 88.58 to 109.18 according to relative valuation methord. Compared to the current price of 78.44 USD , Cabot Corp is Undervalued By 11.45%.
Relative Value
Fair Zone
88.58-109.18
Current Price：78.44
11.45%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.98
P/B
Median3y
3.77
Median5y
3.69
6.80
FCF Yield
Median3y
5.20
Median5y
4.67
Competitors Valuation Multiple
The average P/S ratio for CBT's competitors is 1.43, providing a benchmark for relative valuation. Cabot Corp Corp (CBT) exhibits a P/S ratio of 1.08, which is -24.30% above the industry average. Given its robust revenue growth of -8.15%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Cabot Corp (CBT) currently overvalued or undervalued?
What is Cabot Corp (CBT) fair value?
How does CBT's valuation metrics compare to the industry average?
What is the current P/B ratio for Cabot Corp (CBT) as of Jul 13 2025?
What is the current FCF Yield for Cabot Corp (CBT) as of Jul 13 2025?
What is the current Forward P/E ratio for Cabot Corp (CBT) as of Jul 13 2025?